ORMP News and Press, Oramed Pharmaceuticals Inc. From 06/23/23

2023-06-23 10:02:46 ET Gainers: Conformis ( CFMS ) +91% . TRxADE HEALTH ( MEDS ) +11% . Abcam ( ABCM ) +8% . Lexicon Pharmaceuticals ( LXRX ) +4% . Losers: Beyond Air ( XAIR ) -24% . Oramed Pharmaceuticals ( ORMP ) -...

Oramed to Present at the 83rd American Diabetes Association Conference PR Newswire NEW YORK , June 20, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), announced today that it has been selected to present an ora...

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit PR Newswire NEW YORK , May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: O...

2023-05-16 21:04:48 ET Summary On May 15, Oramed announced that their partner in China had completed a positive phase 3 oral insulin trial in China and had submitted an application to the Chinese regulator. In the same PR, Oramed announced their post-hoc analysis of their failed U...

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 22.36% on the day to $3.83. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions...

2023-05-16 13:08:04 ET Gainers: GD Culture Group Limited ( GDC ) +84% . The Singing Machine Company ( MICS ) +62% . Applied Digital Corporation ( APLD ) +51% . Exela Technologies ( XELA ) +40% . AN2 Therapeutics ( ANTX ) +26% . ...

2023-05-15 09:40:44 ET Oramed Pharmaceuticals ( NASDAQ: ORMP ) has announced the successful completion of Phase 3 trials for oral insulin in type 2 diabetes in China by its strategic partner, Hefei Tianhui Biotechnology (HTIT). The trials were conducted under a differentiated stud...

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China PR Newswire Oramed has completed an analysis of its U.S.-based Phase 3 oral insulin trial with signifi...

2023-05-04 10:46:50 ET Penny stocks are some of the most volatile in the stock market today and for a good reason. A price change of just a few cents can make a significant difference in percentage change in position value. This high-risk scenario has lent itself to present considerable pot...

2023-05-03 02:30:44 ET Conservative political commentator and entrepreneur, Ben Shapiro, has taken a $4.7M stake in struggling Israeli pharma company Oramed Pharmaceuticals ( NASDAQ: ORMP ). The investment will see him join its board of directors and makes him the biggest shareh...